SAN DIEGO - Dare Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company focused on women's health, has been awarded a Notice of Award of a grant from the National Institute of Allergy and ...

Over one crore people were screened as part of the second phase of the lifestyle disease screening, of which over 45 lakh ...

With the devastating 1918 pandemic in mind, US health officials saw an outbreak in Asia and swung into action. What happened ...

While some information has been restored, scientists are still alarmed over the removal of data. It's not clear what has ...

In 2022, chronic lower respiratory disease was the sixth highest cause of death in the U.S., according to results published ...

Two weeks into the Trump administration, external communication from federal health agencies, including the Centers for Disease Control and Prevention, with the nation and world has gone dark. In the ...

Jersey could save nearly £29m by preventing diseases before they need treatment, a new government report has said. In his ...

Homeowners are being advised to stop using bird tables after the Royal Society for the Protection of Birds (RSPB) said they ...

First-of-its-kind treatment to be approved by FDA in more than a decade, Pradalex is now available to treat swine and bovine respiratory diseases.

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

Foodborne illness costs Americans $75 billion annually in premature deaths, medical care and lost productivity, study finds.